Issue Date: October 17, 2011
Shifting Generics To The Super Side
Patents soon expiring on many billion-dollar drugs will lead to a glut of compounds that generic drug producers can duplicate. As a result, near-term generics sales are projected to grow two to three times faster than the overall pharmaceutical market. Yet the drug industry’s current new product drought means a slowing in growth in generics is inevitable.
Large, diversified generics companies may still be able to make money on low-cost, high-volume products, but other companies . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society